Lhrh analogues

Details Lhrh analogues Lhrh analogues

C - Chemistry, Metallurgy

07

K

530/7.06

C07K 7/23 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2039908

900309 RV6 SHAL3.0-008 ABSTRACT OF THE DISCLOSURE The present invention deals with LHRH analogs which contain cytotoxic moieties, have influence on the release of gonadotropins from the pituitary in mammals (possess high agonistic or antagonistic activity) and have antineoplastic effect. The compounds of this invention are represented by Formula 1: X-R1-R2-R3- Ser-R5-R6(Q)-Leu-Arg-Pro-R10-NH2, wherein R1 is pGlu or D-Nal(2), R2 is His or D- Phe(4Cl), R3 is Trp, D-Trp or D-Pal(3), R5 is Tyr or Arg, R6 is D-Lys or D-Orn, R10 is Gly or D-Ala, X is hydrogen or a lower alkanoyl group of 2-5 carbon atoms, Q is a cytotoxic moiety having the formula -Q4 or -A(Q3) or -B(Q1)2 or -B(AQ2)2, wherein A is -NH-(CH2)n-CO- or -OC-(CH2)n-CO- where n is 2-6, B is -NH-CH2-(CH2)m-CH(NH)- (CH2)n-CO- where m is 0 or 1, n is 0 or 1, the -CO moiety of A- and of B- being bonded to an amino group on R6, and in the group B(AQ2)2, the -CO moiety of A- being bonded to an amino group on B, Q1 is D or L-Mel, cyclopropanealkanoyl, aziridine-2-carbonyl, epoxyalkyl or 1,4-naphthoquinone-5-oxycarbonyl-ethyl, Q2 is Q1 anthraquinonylalkoxy or doxorubicinyl, Q3 is Q2, mitomicinyl, esperamycinyl or methotrexoyl, Q4 is Q1 or methotrexoyl and pharmaceutically acceptable salts thereof and methods of use pertaining these compounds.

Affiliated with

Also associated with

Rating

Lhrh analogues does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lhrh analogues, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lhrh analogues will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1398308